ALL

ALL Investors, You Need to Know These Facts Today.

Allstate logged a 0.3% change during today's morning session, and is now trading at a price of $151.41 per share. The S&P 500 index moved 0.0%. ALL's trading volume is 49,760 compared to the stock's average volume of 1,675,278.

Allstate trades -3.52% away from its average analyst target price of $156.94 per share. The 16 analysts following the stock have set target prices ranging from $106.0 to $193.0, and on average have given Allstate a rating of buy.

If you are considering an investment in ALL, you'll want to know the following:

  • Allstate has moved 8.1% over the last year, and the S&P 500 logged a change of 20.0%

  • Based on its trailing earnings per share of -7.99, Allstate has a trailing 12 month Price to Earnings (P/E) ratio of -18.9 while the S&P 500 average is 15.97

  • ALL has a forward P/E ratio of 12.6 based on its forward 12 month price to earnings (EPS) of $12.01 per share

  • The company has a price to earnings growth (PEG) ratio of -0.79 — a number near or below 1 signifying that Allstate is fairly valued compared to its estimated growth potential

  • Its Price to Book (P/B) ratio is 3.15 compared to its sector average of 1.58

  • The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada.

  • Based in Northbrook, the company has 54,000 full time employees and a market cap of $39.62 Billion. Allstate currently returns an annual dividend yield of 2.3%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS